A Phase I, Open-Label, Randomized, 2-Way Crossover Trial in 40 Healthy Subjects to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-State.

Trial Profile

A Phase I, Open-Label, Randomized, 2-Way Crossover Trial in 40 Healthy Subjects to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-State.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Dec 2010

At a glance

  • Drugs Darunavir; Fosamprenavir; Ritonavir; Telaprevir
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 16 Dec 2010 Actual initiation date changed from May 2008 to Jun 2008 as reported by ClinicalTrials.gov.
    • 06 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top